VitaDX
VitaDX is a French deep tech company specializing in AI and digital cytology for healthcare. Founded in April 2015, it leverages patented technology combining imaging and artificial intelligence, developed from research at Institut des Sciences Moléculaires d'Orsay and CHU Bicêtre. The company's mission is to create innovative and effective cancer diagnostic solutions with significant clinical and economic impact. Their first product, VisioCyt® Bladder, is a CE IVDR marked medical device for in-vitro diagnostics that detects bladder cancer from a simple urine sample. This solution offers improved sensitivity and reproducibility compared to conventional urinary cytology and is available through partnerships with pathology labs.
VitaDX
VitaDX is a French deep tech company specializing in AI and digital cytology for healthcare. Founded in April 2015, it leverages patented technology combining imaging and artificial intelligence, developed from research at Institut des Sciences Moléculaires d'Orsay and CHU Bicêtre. The company's mission is to create innovative and effective cancer diagnostic solutions with significant clinical and economic impact. Their first product, VisioCyt® Bladder, is a CE IVDR marked medical device for in-vitro diagnostics that detects bladder cancer from a simple urine sample. This solution offers improved sensitivity and reproducibility compared to conventional urinary cytology and is available through partnerships with pathology labs.